KUgliptin, a Novel and Potent DPP4 Inhibitor, Improves of Combined Therapy with Immune Checkpoint Inhibitor (ICI) in Lung Cancer Immunotherapy

被引：0
|
作者：
Shin, H. S. [1 ]
Choi, J. [1 ]
Lee, S. Y. [1 ]
机构：
[1] Korea Univ, Guro Hosp, Dept Internal Med, Div Pulm, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
immunotherapy of lung cancer; novel and potent DPP4 inhibitor; Immune checkpoint inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P53.04
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [1] Suppression of lung cancer in mice by DPP4 inhibitor Vildagliptin
    Jang, J. -H.
    Janker, F.
    Arni, S.
    Yamada, Y.
    Gil-Bazo, I.
    De Meester, I.
    Weder, W.
    Jungraithmayr, W.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 27 - 27
  • [2] DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes
    Kim, Mi-Kyung
    Chae, Yu Na
    Kim, Ha Dong
    Yang, Eun Kyoung
    Cho, Eun Jung
    Choi, Song-hyen
    Cheong, Ye-Hwang
    Kim, Hae-Sun
    Kim, Heung Jae
    Jo, Yeong Woo
    Son, Moon-Ho
    Kim, Soon-Hoe
    Shin, Chang Yell
    LIFE SCIENCES, 2012, 90 (1-2) : 21 - 29
  • [3] Treatment trends with immune checkpoint inhibitor (ICI) therapy in older adults with lung cancer.
    Walko, Christine Marie
    Dickey, Allison
    Motsinger-Reif, Alison A.
    Scholl, Elizabeth
    McLeod, Howard L.
    Hauser, Robert Sean
    Van Londen, G. J.
    Singh, Harpreet
    Simon, Jody
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
    Xiong, Wei
    Zhao, Yunfeng
    Du, He
    Guo, Xuejun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Characteristics of DA-1229, a novel, highly potent and selective DPP4 inhibitor
    Kim, Heung Jae
    Kim, Ha Dong
    Kwak, Woo Young
    Shin, Chang Yell
    Min, Jong Pil
    Yoon, Tae Hyun
    Lee, Jae Young
    Choi, Song Hyen
    Kim, Hae Sun
    Chae, Yuna
    Yang, Eun Kyoung
    Cheong, Ye Hwang
    Park, Kyung Jin
    Jang, Ji Myun
    Choi, Soo Jung
    Kim, Mi Kyung
    Son, Moon Ho
    Kim, Soon Hoe
    Yoo, Moohi
    DIABETES, 2008, 57 : A710 - A711
  • [6] Suppression of Lung Cancer Growth by CD26/DPP4 Inhibitor
    Jang, Jae-Hwi
    Janker, Florian
    Arni, Stephan
    Yamada, Yoshito
    Gil-Bazo, Ignacio
    Meester, Ingrid D.
    Weder, Walter
    Jungraithmayr, Wolfgang
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S314 - S314
  • [7] Clinical markers of glycaemic response to DPP4 inhibitor therapy
    Ivone Leong
    Nature Reviews Endocrinology, 2018, 14 : 191 - 191
  • [8] The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
    Wang, Chengdi
    Li, Jingwei
    Zhang, Qiran
    Wu, Jiayang
    Xiao, Yuxuan
    Song, Lujia
    Gong, Hanlin
    Li, Yalun
    BMC CANCER, 2021, 21 (01)
  • [9] The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
    Chengdi Wang
    Jingwei Li
    Qiran Zhang
    Jiayang Wu
    Yuxuan Xiao
    Lujia Song
    Hanlin Gong
    Yalun Li
    BMC Cancer, 21
  • [10] ENDOCRINE EMERGENCIES IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR LUNG CANCER
    Fowler, Cosmo
    Nangia, Vaibhuv
    Goldberg, Daniel
    Chism, Lauren
    Pastores, Stephen
    CRITICAL CARE MEDICINE, 2024, 52
12345